ANDA 80409, held by Hospira. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 80409 (Lta Ii Kit), held by Hospira, was first approved by FDA on Apr 6, 1972, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 6, 1972 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lta Ii Kit4% ยท solution;topical | Lidocaine Hydrochloride | Discontinued |
| Jun 4, 1992 | Supplement 28Labeling | Approved | None posted |
| Jun 4, 1992 | Supplement 14Labeling | Approved | None posted |
| Jun 4, 1992 | Supplement 13Manufacturing | Approved | None posted |
| Jun 13, 1989 | Supplement 27Manufacturing | Approved | None posted |
| Jul 25, 1986 | Supplement 26Manufacturing | Approved | None posted |
| Aug 9, 1985 | Supplement 25Manufacturing | Approved | None posted |
| Jul 19, 1982 | Supplement 22Manufacturing | Approved | None posted |
| Jun 24, 1981 | Supplement 21Manufacturing | Approved | None posted |
| Apr 6, 1972 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters